Published on: 10/28/2026
This news was posted by Oregon Today News
Description
Eli Lilly's experimental drug retatrutide showed greater reduction in A1C and double the average weight loss in a head-to-head clinical study against Ozempic.
Other Related News
10/28/2026
Records show executive pay soared as Medicine Wheel tapped into Medicaid while flying Nati...
10/28/2026
Four medical groups unveiled a lifelong heart health roadmap for women from first period t...
10/28/2026
An man reportedly entered an apartment in southeast Canby assaulted a 12-year-old child an...
10/28/2026
Requests for Letters from Wintertime Characters open Sunday November 1 To celebrate the wi...
10/28/2026
